Delivery Order SPE2DB20D2014-SPE2DB25FC14K
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,695.65 on September 10, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion deadline of September 11, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a continuation of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,622.82 to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The order is scheduled for ultimate completion by June 18, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency has awarded a delivery order valued at $18,916.95 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This competitive award, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count) valued at $1,412.73, with an ultimate completion date of June 5, 2025. This competitively awarded, non-set-aside delivery order employs firm fixed price terms and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a $32,989.70 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside, firm fixed-price contract was awarded through open competition and reflects AmerisourceBergen's established role as a critical pharmaceutical distributor within the federal medical supply chain. The delivery order is being performed at...
- The Defense Logistics Agency awarded a delivery order valued at $45,433.69 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units). This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,903.32 to AmerisourceBergen Drug Corp for the supply of Entresto 49 mg-51 mg tablets (60-count units) on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $29,942.46 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Entresto 24 mg-26 mg tablets (180 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $6,748.34 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, PA, with an ultimate completion date of August 13, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $22,550.03 delivery order to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (180-count units) under a firm fixed price contract type. The order was competitively awarded without set-aside designation and carries an ultimate completion date of September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this procurement action. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC14KDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $37,426.25 firm fixed-price delivery order on June 6, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count units). This non-set-aside, competitively awarded contract is scheduled for completion by June 9, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical federal medical procurement vendor, particularly through its extensive contract portfolio with the DLA Medical Supply Chain. The company's federal awards demonstrate broad capability across multiple therapeutic domains, including specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices. All reviewed contract awards reflect competitive procurement practices with firm fixed pricing structures, ranging from nominal transactions to substantial orders exceeding $45,000, enabling AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.4k | 6/6/25 |